This is one in a series of articles highlighting the key people leading Big Tech companies’ move into digital health and life sciences. Read earlier stories about Verily, Amazon, Apple, Microsoft, and Google.

SAN FRANCISCO — When it comes to building out a health business, Facebook is often seen as having much more modest ambitions than its Big Tech competitors. If that was ever true, it’s looking less so now — even as the company faces a backlash over revelations about its use of customers’ personal information.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy